These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 16137513)

  • 1. A controlled study on the effect of verapamil on atrial tachycaarrhythmias in patients with brady-tachy syndrome implanted with a DDDR pacemaker.
    Boriani G; Bertaglia E; Carboni A; Latini R; Biffi M; Martignani C; Sciotto F; Branzi A
    Int J Cardiol; 2005 Sep; 104(1):73-6. PubMed ID: 16137513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overdrive versus conventional or closed-loop rate modulation pacing in the prevention of atrial tachyarrhythmias in Brady-Tachy syndrome: on behalf of the Burden II Study Group.
    Puglisi A; Favale S; Scipione P; Melissano D; Pavia L; Ascani F; Elia M; Scaccia A; Sagone A; Castaldi B; Musacchio E; Botto GL;
    Pacing Clin Electrophysiol; 2008 Nov; 31(11):1443-55. PubMed ID: 18950302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial tachyarrhythmia burden modelling by some electrophysiological parameters in pacemaker-recipient patients with Brady-Tachy syndrome.
    Azzolini P; Critelli G; De Giorgi V; Del Giudice GB; Ibba G; Melissano D; Scaccia A; Puglisi A
    Europace; 2006 Jul; 8(7):474-81. PubMed ID: 16798759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Drug And Pace Health cliNical Evaluation (DAPHNE) study: a randomized trial comparing sotalol versus beta-blockers to treat symptomatic atrial fibrillation in patients with brady-tachycardia syndrome implanted with an antitachycardia pacemaker.
    Capucci A; Botto G; Molon G; Spampinato A; Favale S; Proclemer A; Porfilio A; Marotta T; Vimercati M; Boriani G;
    Am Heart J; 2008 Aug; 156(2):373.e1-8. PubMed ID: 18657671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiarrhythmic benefits of dual chamber stimulation with rate-response in patients with paroxysmal atrial fibrillation and chronotropic incompetence: a prospective, multicentre study.
    Bellocci F; Spampinato A; Ricci R; Puglisi A; Capucci A; Dini P; Boriani G; Botto G; Curnis A; Moracchini PV; Nicotra G; Lisi F; Nigro P
    Europace; 1999 Oct; 1(4):220-5. PubMed ID: 11220558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased base rate of atrial pacing for prevention of atrial fibrillation after implantation of a dual-chamber pacemaker: insights from the Atrial Overdrive Pacing Study.
    Kantharia BK; Freedman RA; Hoekenga D; Tomassoni G; Worley S; Sorrentino R; Steinhaus D; Wolkowicz JM; Syed ZA;
    Europace; 2007 Nov; 9(11):1024-30. PubMed ID: 17913697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A preliminary study on the role of anti-atrial fibrillation pacemaker in the prevention of atrial tachyarrhythmia].
    Yang JF; Tong JB; Wang ZL; Zhou T; Li M; Wu SJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Sep; 33(9):824-6. PubMed ID: 16266459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of atrial antitachycardia pacing efficacy in patients affected by brady-tachy form of sick sinus syndrome and implanted with a DDDRP device.
    Boriani G; Padeletti L; Santini M; Gulizia M; Capucci A; Botto G; Ricci R; Molon G; Accogli M; Vicentini A; Biffi M; Vimercati M; Grammatico A
    J Cardiovasc Electrophysiol; 2005 Jul; 16(7):714-23. PubMed ID: 16050828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights into long-term follow-up of atrial fibrillation ablation: full disclosure by an implantable pacemaker device.
    Martinek M; Aichinger J; Nesser HJ; Ziegler PD; Purerfellner H
    J Cardiovasc Electrophysiol; 2007 Aug; 18(8):818-23. PubMed ID: 17573835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of antitachycardia pacemaker on atrial tachyarrhythmia detection, prevention and termination].
    Bai R; Wang TM; Lin L; Kam R; Wee St; Wang L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr; 34(4):333-7. PubMed ID: 16776927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Device treatment of atrial tachycardia--minor additional effect of repeating pacing sequences.
    Schuster P; Faerestrand S; Ohm OJ
    Int J Cardiol; 2005 Sep; 104(1):10-4. PubMed ID: 16137503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brady-tachy syndrome: rapid atrial pacing efficacy in preventing atrial fibrillation recurrence assessed by reliable electrograms: the prefib pilot study.
    Flammang D; Loteanu V; Hamani D; Lambiez M; Flammang-Dorie G
    Europace; 2005 Sep; 7(5):482-9. PubMed ID: 16087114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of atrial fibrillation burden by atrial overdrive pacing: experience with an improved algorithm to reduce early recurrences of atrial fibrillation.
    Pürerfellner H; Urban L; de Weerd G; Ruiter J; Brandt J; Havlicek A; Hügl B; Widdershoven J; Kornet L; Kessels R
    Europace; 2009 Jan; 11(1):62-9. PubMed ID: 19008238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of anti-tachycardia pacing on atrial fibrillation burden when added on top of preventive pacing algorithms: results of the prevention or termination (POT) trial.
    Mont L; Ruiz-Granell R; Martínez JG; Carmona JR; Fidalgo M; Cobo E; Riera M; Navarro X;
    Europace; 2008 Jan; 10(1):28-34. PubMed ID: 18199572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of atrial tachyarrhythmia burden with an implantable pacemaker before and after pulmonary vein isolation.
    Pürerfellner H; Aichinger J; Martinek M; Nesser HJ; Ziegler P; Koehler J; Warman E; Hettrick D
    Pacing Clin Electrophysiol; 2004 Sep; 27(9):1277-83. PubMed ID: 15461719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial tachyarrhythmia recurrence temporal patterns in bradycardia patients implanted with antitachycardia pacemakers.
    Ricci R; Santini M; Padeletti L; Boriani G; Capucci A; Botto G; Gulizia M; Inama G; Galati A; Solimene F; Pepe M; Grammatico A
    J Cardiovasc Electrophysiol; 2004 Jan; 15(1):44-51. PubMed ID: 15028071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individualized selection of pacing algorithms for the prevention of recurrent atrial fibrillation: Results from the VIP registry.
    Lewalter T; Yang A; Pfeiffer D; Ruiter J; Schnitzler G; Markert T; Asklund M; Przibille O; Welz A; Esmailzadeh B; Linhart M; Lüderitz B
    Pacing Clin Electrophysiol; 2006 Feb; 29(2):124-34. PubMed ID: 16492296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized comparison between Ramp and Burst+ atrial antitachycardia pacing therapies in patients suffering from sinus node disease and atrial fibrillation and implanted with a DDDRP device.
    Gulizia M; Mangiameli S; Orazi S; Chiarandà G; Boriani G; Piccione G; DiGiovanni N; Colletti A; Puntrello C; Butera G; Vasco C; Vaccaro I; Scardace G; Grammatico A;
    Europace; 2006 Jul; 8(7):465-73. PubMed ID: 16798758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of ventricular tachyarrhythmia by treatment of atrial fibrillation in ICD patients with dual-chamber implantable cardioverter/defibrillators capable of atrial therapy delivery: the REVERT-AF Study.
    Gradaus R; Seidl K; Korte T; Himmrich E; Wieneke H; Schuchert A; Bauer W; Gerss J; Wollmann CG; Borggrefe M; Böcker D
    Europace; 2007 Jul; 9(7):534-9. PubMed ID: 17440005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of continuous overdrive atrial pacing in atrial fibrillation.
    Lam CT; Lau CP; Leung SK; Tse HF; Lee KL; Tang MO; Tsang V
    Europace; 2000 Oct; 2(4):286-91. PubMed ID: 11194594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.